CVS Health Corp (NYSE: CVS) kicked off on Monday, down -0.52% from the previous trading day, before settling in for the closing price of $61.96. Over the past 52 weeks, CVS has traded in a range of $43.56-$72.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -6.37% over the past five years. While this was happening, its average annual earnings per share was recorded 13.14%. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.27 billion.
Let’s look at the performance matrix of the company that is accounted for 300000 employees. In terms of profitability, gross margin is 14.05%, operating margin of 2.54%, and the pretax margin is 1.9%.
CVS Health Corp (CVS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of CVS Health Corp is 0.15%, while institutional ownership is 86.79%. The most recent insider transaction that took place on Jun 05 ’25, was worth 100,009. In this transaction Director of this company bought 1,570 shares at a rate of $63.70, taking the stock ownership to the 12,007 shares. Before that another transaction happened on May 02 ’25, when Company’s Director sold 2,276,068 for $67.86, making the entire transaction worth $154,444,758. This insider now owns 9,670,731 shares in total.
CVS Health Corp (CVS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.07% during the next five years compared to -6.37% drop over the previous five years of trading.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
Take a look at CVS Health Corp’s (CVS) current performance indicators. Last quarter, stock had a quick ratio of 0.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.21. Likewise, its price to free cash flow for the trailing twelve months is 13.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.19, a number that is poised to hit 1.46 in the next quarter and is forecasted to reach 7.04 in one year’s time.
